Regeneron Pharmaceuticals, Inc. (REGN)
621.46
-6.28
(-1.00%)
USD |
NASDAQ |
May 28, 16:00
623.00
+1.54
(+0.25%)
After-Hours: 19:22
Regeneron Pharmaceuticals Research and Development Expense (Annual) : 5.306B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 6.974B |
| AbbVie, Inc. | 8.249B |
| Biogen, Inc. | 1.481B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |